Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D05BCF
|
||||
| Former ID |
DNC000445
|
||||
| Drug Name |
Clavulanate+Amoxicillin
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Infections [ICD9: 001-139; ICD10:A00-B99] | Investigative | [1] | ||
| Company |
GlaxoSmithKline
|
||||
| Structure |
|
Download2D MOL |
|||
| Formula |
C8H8KNO5
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Beta-lactamase | Target Info | Inhibitor | [1] | |
| References | |||||
| REF 1 | Emerging therapies for the treatment and prevention of otitis media. Expert Opin Emerg Drugs. 2006 May;11(2):251-64. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.